ALS-08

DB05705ExperimentalSmall molecule

ALS-08 is a proprietary creatine-derivative that is being developed as a potential therapeutic for amyotrophic lateral sclerosis (ALS). It is being developed by Avicena Group, Inc.

Primary indication
Investigated for use/treatment in amyotrophic lateral sclerosis (ALS).Curator reviewed
Code names
ALS-08

Which companies are running trials of ALS-08, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account